首页> 外文期刊>Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association >Vascular calcification and 25-hydroxyvitamin D levels in non-dialysis patients with chronic kidney disease stages 4 and 5.
【24h】

Vascular calcification and 25-hydroxyvitamin D levels in non-dialysis patients with chronic kidney disease stages 4 and 5.

机译:慢性肾脏病4和5期非透析患者的血管钙化和25-羟基维生素D水平

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Cardiovascular disease (CVD) is the leading cause of death among chronic kidney disease (CKD) patients. Vascular calcification is highly prevalent in this population and is an independent predictor of cardiovascular mortality. Vascular calcification in uraemic patients is known to be an active and regulated process subject to the action of many promoting and inhibitory factors. The role of vitamin D in this process remains controversial. We evaluated the relationship between serum levels of 25-hydroxyvitamin D (25(OH)D) and vascular calcification evaluated by plain X-ray images, in predialysis patients with CKD stages 4 and 5. METHODS: We performed a cross-sectional study with 210 CKD patients stages 4 and 5 managed at our predialysis unit. Patients were 63.5 +/- 13 years of age, 60.5% males, 64.8% diabetics and 47.1% with a history of CVD. Plain X-ray images of pelvis, hands and lateral lumbar spine from all subjects were studied for calculation of semiquantitative vascular calcification scores as described by Adragao and Kauppila. RESULTS: We found a high prevalence of vascular calcification in our population. Adragao scores revealed only 47 patients (22.4%) without vascular calcification and 120 (57.1%) with scores higher than 3. Kauppila scores revealed only 29 patients (13.8%) without aortic calcifications and 114 patients (54.3%) with scores higher than 7. Higher vascular calcification scores were related to older age, diabetes, history of CVD and lower levels of 25(OH)D. Only 18.5% of patients had adequate levels of 25(OH)D (> 30 ng/mL), 53.7% of them had insufficient levels (15-30 ng/mL) and 27.8% had deficient levels (< 15 ng/mL). Multivariate analysis showed that age, diabetes and CVD were directly associated and 25(OH)D levels were inversely associated with vascular calcifications. CONCLUSIONS: Our results show an independent and negative association between serum levels of 25(OH)D and vascular calcification. Further and larger prospective studies are needed to clarify the possible role of vitamin D deficiency in the development of vascular calcification in CKD patients.
机译:背景:心血管疾病(CVD)是慢性肾脏病(CKD)患者死亡的主要原因。血管钙化在这一人群中非常普遍,是心血管疾病死亡率的独立预测因子。尿毒症患者的血管钙化是受许多促进和抑制因素作用的活跃且受调节的过程。维生素D在此过程中的作用仍存在争议。我们评估了CKD 4和5期透析前患者血清25-羟基维生素D(25(OH)D)水平与通过普通X射线照片评估的血管钙化之间的关系。方法:在我们的透析前部门管理了210名CKD患者的4和5期。患者为63.5 +/- 13岁,男性为60.5%,糖尿病患者为64.8%,有CVD病史的为47.1%。如Adragao和Kauppila所述,研究了所有受试者的骨盆,手和腰外侧脊柱的X射线平片图像,以计算半定量血管钙化分数。结果:我们发现人群中血管钙化的发生率很高。 Adragao评分仅显示47例(22.4%)无血管钙化,120例(57.1%)高于3。Kauppila评分仅显示29例(13.8%)无主动脉钙化,114例(54.3%)高于7分。 。较高的血管钙化分数与年龄,糖尿病,CVD史和较低的25(OH)D水平有关。只有18.5%的患者具有足够的25(OH)D(> 30 ng / mL)水平,其中53.7%的患者具有不足的水平(15-30 ng / mL)和27.8%的患者具有不足的水平(<15 ng / mL) 。多变量分析表明,年龄,糖尿病和CVD与血管钙化成正比,而25(OH)D水平与血管钙化成反比。结论:我们的结果显示血清25(OH)D水平与血管钙化之间存在独立且负相关的关系。需要进一步的前瞻性研究来阐明维生素D缺乏在CKD患者血管钙化发展中的可能作用。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号